← Back to Clinical Trials
Recruiting NCT06725459

NPWT Reduction Mammaplasty

Trial Parameters

Condition Healthy
Sponsor Medstar Health Research Institute
Study Type INTERVENTIONAL
Phase N/A
Enrollment 92
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2024-12-17
Completion 2026-07-01
Interventions
Prophylactic ciNPWTStandard Adhesive Dressing

Brief Summary

In this prospective, randomized, split-body control trial, we aim to compare complications, patient-reported outcomes, and cost differentials following reduction mammaplasty with prophylactic closed incision negative pressure wound therapy versus standard adhesive dressing.

Eligibility Criteria

Inclusion Criteria: * Female patients * Age 18 years or older * Scheduled to undergo bilateral reduction mammaplasty with a Wise pattern (anchor) incision and a superomedial, inferior, or central mound pedicle at MedStar Georgetown University Hospital or MedStar Good Samaritan Hospital * Able to comply with study procedures and follow-up visits Exclusion Criteria: * Younger than 18 years of age * Biologically male patients * Scheduled to undergo unilateral breast mammaplasty * Currently pregnant or lactating * Use of steroids or other immune modulators known to affect wound healing * Current smokers who have not paused for a minimum of 4 weeks prior to surgery * History of breast cancer * History of oncologic or reconstructive breast surgery * History of radiation to the breast * History of chemotherapy or hormone therapy * Tattoos in the area of skin incision * Skin conditions known to affect wound healing or scarring of the breast (e.g., cutis laxa) * Significant history of scar prob

Related Trials